The companies behind the Pfizer vaccine are nearly ready to seek approval for the jab’s use among children as young as five years old and should make that request within the next few weeks, the founders of vaccine maker BioNTech said in an interview published Friday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,